Functional rescue of the inactive splice variant of the dopamine D 3 receptor D3nf

Brain Research

Volumn 987, Issue 2, 2003, Pages 244-247

  Scarselli, Marco ^a   Novi, Francesca ^a   Corsini, Giovanni U ^a   Maggio, Roberto ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

Adenylyl cyclase; D 3; D3nf; Dopamine; Receptor; Splice variant

Indexed keywords

2 DIPROPYLAMINO 7 HYDROXYTETRALIN; CLOZAPINE; DOPAMINE; DOPAMINE 3 RECEPTOR; DOPAMINE 3 RECEPTOR BLOCKING AGENT; DOPAMINE 3 RECEPTOR STIMULATING AGENT; EMONAPRIDE; HALOPERIDOL;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DRUG RECEPTOR BINDING; GENETIC TRANSFECTION; GENETIC VARIABILITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN VARIANT;

EID: 0142038894     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(03)03360-2     Document Type: Article

References (16)

1. Avidor-Reiss T., Bayewitch M., Levy R., Matus-Leibovitch N., Nevo I., Vogel Z. Adenylylcyclase supersensitization in mu-opioid receptor-transfected Chinese hamster ovary cells following chronic opioid treatment. J. Biol. Chem. 270:1995;29732-29738.
2. 50) of an enzymatic reaction. Biochem. Pharmacol. 22:1973;3099-3108.
3. Cullen B.R. Use of eukaryotic expression technology in the functional analysis of cloned genes. Methods Enzymol. 152:1987;684-704.
4. 3 dopamine receptor: evidence for hetero-oligomerization. Mol. Brain Res. 80:2000;63-74.
5. 3 dopamine receptor produced through various alternative splicing. Biochem. Biophys. Res. Commun. 176:(3):1991;1584-1592.
6. 3 receptors. Mol. Pharmacol. 58:2000;677-683.
7. Kilpatrick G.J., Dautzenberg F.M., Martin G.R., Eglen R.M. 7TM receptors: the splicing on the cake. TIPS. 20:1999;294-301.
8. 3 dopamine receptor: neurobiology and potential clinical relevance. Pharmacol. Rev. 49:1997;231-252.
9. Maggio R., Vogel Z., Wess J. Coexpression studies with mutant muscarinic/adrenergic receptors provide evidence for intermolecular 'cross-talk' between G-protein-linked receptors. Proc. Natl. Acad. Sci. USA. 90:1993;3103-3107.
10. Nagai Y., Ueno S., Saeki Y., Soga F., Yanagihara T. Expression of the D3 dopamine receptor gene and a novel variant transcript generated by alternative splicing in human peripheral blood lymphocytes. Biochem. Biophys. Res. Commun. 194:(1):1993;368-374.
11. 3 receptor. Mol. Pharmacol. 52:1997;508-514.
12. 2s receptor by co-expression of amino- and carboxyl-terminal receptor fragments. Eur. J. Pharmacol. 397:2000;291-296.
13. 3 dopamine receptor heterodimers exhibit unique functional properties. J. Biol. Chem. 276:2001;30308-30314.
14. Schmauss C., Haroutunian V., Davis K.L., Davidson M. Selective loss of dopamine D3-type receptor mRNA expression in parietal and motor cortices of patients with chronic schizophrenia. Proc. Natl. Acad. Sci. USA. 90:1993;8942-8946.
15. 2 vasopressin receptors causing nephrogenic diabetes insipidus by a co-expressed receptor polypeptide. EMBO J. 15:1996;1283-1291.
16. 3 receptor. Biochem. Biophys. Res. Commun. 180:1991;1031-1035.